TY - JOUR
T1 - In vivo evaluation of mixtures of uncultured freshly isolated adipose-derived stem cells and demineralized bone matrix for bone regeneration in a rat critically sized calvarial defect model
AU - Rhee, Seung Chul
AU - Ji, Yi Hwa
AU - Gharibjanian, Nareg A.
AU - Dhong, Eun Sang
AU - Park, Seung Ha
AU - Yoon, Eul Sik
PY - 2011/2/1
Y1 - 2011/2/1
N2 - Although many studies have suggested that human adipose tissue contains pluripotent stem cells, a few reports are available on stromal vascular fraction (SVF). In the present study, we evaluated the bone formation capacities of SVF. We implanted uncultured freshly isolated adipose-derived stem cells combined with demineralized bone matrix (DBM) to induce bone regeneration in a critically sized rat calvarial defect model. We used DBM (DBX®) and/or poly(70l-lactide-co-30dl-lactide) copolymer PLA as a scaffold. Fifty white rats were randomized to 5 different groups (n=10): (1) control, (2) DBM, (3) DBM+SVF, (4) DBM+PLA, and (5) DBM+PLA+SVF groups. After acquiring SVF, an 8-mm critically sized calvarial defect was made in each rat. Specimens were harvested at 8 weeks postimplantation and evaluated radiographically and histologically. New bone formation was qualified by hematoxylin and eosin staining and anti-osteocalcin antibody (OC4-30) immunostaining of calvarial sections. Amounts of mineralization were determined by radiodensitometric analysis. In gross appearance, the DBM+SVF and DBM+PLA+SVF groups showed more abundant bone formation than the other groups. Radiodensitometric evaluations revealed that significant intergroup differences were observed according to the Kruskal-Wallis (rank) test (P=0.030<0.05). The 5 groups show different amounts of filling of bone defects (control: 13.48%; DBM: 39.94%; DBM+SVF: 57.69%; DBM+PLA: 24.86%; DBM+PLA+SVF: 42.75%). Histological evaluation revealed that there was abundant new bone formation in the DBM+SVF and DBM+PLA+SVF groups. It was found that undifferentiated adipose-derived stem cells in the form of SVF induced new bone formation in rat calvarial defects. Accordingly, SVF offers a practical, promising candidate for regenerative tissue engineering or cell-based therapy.
AB - Although many studies have suggested that human adipose tissue contains pluripotent stem cells, a few reports are available on stromal vascular fraction (SVF). In the present study, we evaluated the bone formation capacities of SVF. We implanted uncultured freshly isolated adipose-derived stem cells combined with demineralized bone matrix (DBM) to induce bone regeneration in a critically sized rat calvarial defect model. We used DBM (DBX®) and/or poly(70l-lactide-co-30dl-lactide) copolymer PLA as a scaffold. Fifty white rats were randomized to 5 different groups (n=10): (1) control, (2) DBM, (3) DBM+SVF, (4) DBM+PLA, and (5) DBM+PLA+SVF groups. After acquiring SVF, an 8-mm critically sized calvarial defect was made in each rat. Specimens were harvested at 8 weeks postimplantation and evaluated radiographically and histologically. New bone formation was qualified by hematoxylin and eosin staining and anti-osteocalcin antibody (OC4-30) immunostaining of calvarial sections. Amounts of mineralization were determined by radiodensitometric analysis. In gross appearance, the DBM+SVF and DBM+PLA+SVF groups showed more abundant bone formation than the other groups. Radiodensitometric evaluations revealed that significant intergroup differences were observed according to the Kruskal-Wallis (rank) test (P=0.030<0.05). The 5 groups show different amounts of filling of bone defects (control: 13.48%; DBM: 39.94%; DBM+SVF: 57.69%; DBM+PLA: 24.86%; DBM+PLA+SVF: 42.75%). Histological evaluation revealed that there was abundant new bone formation in the DBM+SVF and DBM+PLA+SVF groups. It was found that undifferentiated adipose-derived stem cells in the form of SVF induced new bone formation in rat calvarial defects. Accordingly, SVF offers a practical, promising candidate for regenerative tissue engineering or cell-based therapy.
UR - http://www.scopus.com/inward/record.url?scp=78951477715&partnerID=8YFLogxK
U2 - 10.1089/scd.2009.0525
DO - 10.1089/scd.2009.0525
M3 - Article
C2 - 20528145
AN - SCOPUS:78951477715
SN - 1547-3287
VL - 20
SP - 233
EP - 242
JO - Stem cells and development
JF - Stem cells and development
IS - 2
ER -